178 related articles for article (PubMed ID: 3116371)
41. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma).
Fukazawa Y; Kagaya K; Miura H; Shinoda T; Natori K; Yamazaki S
Microbiol Immunol; 1984; 28(6):691-702. PubMed ID: 6434908
[TBL] [Abstract][Full Text] [Related]
42. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
Nathan CF; Murray HW; Wiebe ME; Rubin BY
J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
[TBL] [Abstract][Full Text] [Related]
43. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
44. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
Pidgeon C; Schreiber RD; Schultz RM
J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
[TBL] [Abstract][Full Text] [Related]
45. Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni.
Esparza I; Männel D; Ruppel A; Falk W; Krammer PH
J Exp Med; 1987 Aug; 166(2):589-94. PubMed ID: 3110355
[TBL] [Abstract][Full Text] [Related]
46. Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma.
Le J; Vilcek J
Cell Immunol; 1984 Apr; 85(1):278-83. PubMed ID: 6424948
[TBL] [Abstract][Full Text] [Related]
47. A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF).
Jones MP; Gunapala DE; Matutes E; Catovsky D; Coates AR
Cell Immunol; 1988 May; 113(2):361-75. PubMed ID: 2834073
[TBL] [Abstract][Full Text] [Related]
48. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
49. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.
Schreiber RD
Contemp Top Immunobiol; 1984; 13():171-98. PubMed ID: 6428805
[No Abstract] [Full Text] [Related]
50. Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.
Yamamoto Y; Tomida M; Hozumi M
Gan; 1982 Aug; 73(4):557-64. PubMed ID: 6818089
[TBL] [Abstract][Full Text] [Related]
51. Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?
Zlotnik A; Roberts WK; Vasil A; Blumenthal E; Larosa F; Leibson HJ; Endres RO; Graham SD; White J; Hill J; Henson P; Klein JR; Bevan MJ; Marrack P; Kappler JW
J Immunol; 1983 Aug; 131(2):794-800. PubMed ID: 6223094
[TBL] [Abstract][Full Text] [Related]
52. Regulation of murine macrophage function by IL-4. I. Activation of macrophages by a T-T cell hybridoma is due to IL-4.
Somers SD; Erickson KL
Cell Immunol; 1989 Aug; 122(1):178-87. PubMed ID: 2502316
[TBL] [Abstract][Full Text] [Related]
53. Macrophage activation by OM-85 BV.
Mauël J
Respiration; 1992; 59 Suppl 3():14-8. PubMed ID: 1332156
[TBL] [Abstract][Full Text] [Related]
54. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
55. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
56. Translation of human macrophage activating factor (for glucose consumption) mRNA in Xenopus laevis oocytes.
Ishii Y; Osada H; Kobayashi Y; Obinata M; Natori S; Osawa T
Immunol Invest; 1985 Apr; 14(2):95-103. PubMed ID: 3891606
[TBL] [Abstract][Full Text] [Related]
57. Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).
Van Niel A; Zacks SE; David JR; Remold HG; Weiser WY
Adv Exp Med Biol; 1988; 239():231-7. PubMed ID: 3059767
[TBL] [Abstract][Full Text] [Related]
58. Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cells.
Jones CM; Prince CA; Langford MP; Hester JP
J Immunol; 1986 Jul; 137(2):571-7. PubMed ID: 3088103
[TBL] [Abstract][Full Text] [Related]
59. Production of C3 as a marker of lymphokine-mediated macrophage activation.
Koestler TP; Kirsh R; Kline T; Rieman D; Greig R; Poste G
Cell Immunol; 1984 Aug; 87(1):1-14. PubMed ID: 6378389
[TBL] [Abstract][Full Text] [Related]
60. Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2.
Krammer PH; Kubelka CF; Falk W; Ruppel A
J Immunol; 1985 Nov; 135(5):3258-63. PubMed ID: 3930600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
